IVMED-50

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIVMED-50
Drug Alias NameAAV vector-based gene therapy (iVeena)IVMED-50
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesiVeena LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesiVeena LLC
Active IndicationsN/A
Inactive IndicationsWet age-related macular degeneration

Other Information

ATC CodeN/A
Related LinksN/A